Latest filings (excl ownership)
No filings
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
15 May 24
4
Kinnate Biopharma Inc.
5 Apr 24
13F-HR
Quarterly holdings report by institutional manager
13 Feb 24
13F-HR
Quarterly holdings report by institutional manager
13 Nov 23
4
James B. Tananbaum
31 Aug 23
13F-HR
Quarterly holdings report by institutional manager
11 Aug 23
4
James B. Tananbaum
19 Jul 23
13F-HR
Quarterly holdings report by institutional manager
12 May 23
4
Kinnate Biopharma Inc.
10 May 23
4
James B. Tananbaum
6 Apr 23
4
Kinnate Biopharma Inc.
22 Feb 23
13F-HR
Quarterly holdings report by institutional manager
13 Feb 23
4
James B. Tananbaum
3 Jan 23
4
James B. Tananbaum
5 Dec 22
13F-HR
Quarterly holdings report by institutional manager
14 Nov 22
13F-HR
Quarterly holdings report by institutional manager
12 Aug 22
3
James B. Tananbaum
13 Jun 22
4/A
James B. Tananbaum
10 Jun 22
13F-HR
Quarterly holdings report by institutional manager
13 May 22
13F-HR
Quarterly holdings report by institutional manager
11 Feb 22
4/A
James B. Tananbaum
30 Dec 21
4
James B. Tananbaum
28 Dec 21
4
James B. Tananbaum
23 Dec 21
13F-HR
Quarterly holdings report by institutional manager
12 Nov 21
4
James B. Tananbaum
3 Nov 21
13F-HR
Quarterly holdings report by institutional manager
16 Aug 21
13F-HR
Quarterly holdings report by institutional manager
17 May 21
4
James B. Tananbaum
23 Feb 21
3
FS Development Corp. II
16 Feb 21
13F-HR
Quarterly holdings report by institutional manager
16 Feb 21
3
James B. Tananbaum
10 Feb 21
4
Gemini Therapeutics, Inc. /DE
9 Feb 21
4
Kinnate Biopharma Inc.
9 Dec 20
4
Kinnate Biopharma Inc.
4 Dec 20
3
Kinnate Biopharma Inc.
3 Dec 20
4
James B. Tananbaum
19 Oct 20
3/A
FS Development Corp.
19 Aug 20